Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) in prostate cancer: PSMA-RADS classification and PROMISE criterias

被引：0
|
作者：
Robin, P. [1 ,2 ,5 ]
Palard-Novello, X. [3 ,4 ]
Bailly, C.
机构：
[1] Ctr Hosp Univ Brest, Serv Med Nucl, 2 Ave Foch, F-29269 Brest, France
[2] Univ Brest, CHU Brest, UMR 1304, Inserm, Brest, France
[3] Univ Rennes, CLCC Eugene Marquis, INSERM, LTSI UMR 1099, Ave Bataille Flandres Dunkerque, F-35042 Rennes, France
[4] Ctr Hosp Univ Nantes, Serv Med Nucl, Nantes, France
[5] Univ Brest, Ctr Hosp & Univ Brest, Inserm, UMR 1304,CHRU Brest,GETBO,Serv Med Nucl, 2 Ave Foch, F-29609 Brest, France
来源：
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2023年 / 47卷 / 05期
关键词：
Positron emission tomography; Prostate specific membrane antigen; receptor; Prostate cancer; Classifications; VERSION; PEARLS; EANM;
D O I：
10.1016/j.mednuc.2023.07.005
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) is nowadays widely used for the management of patients with prostate cancer during natural history of the disease. PSMA is not specific to prostate tissue, many benign and malignant diseases unrelated to prostate cancer are frequently found on PSMA-PET examinations, leading to false positives results and potentially to inadequate patient management. Various interpretation criteria have been proposed within classifications in order to standardize and homogenize PSMA-PET interpretation. This article describes, on the one hand the PSMA-RADS classification, and on the other hand the PROMISE criteria. (c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：270 / 275
页数：6
相关论文
共 50 条
  • [41] Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer
    Shayegan, Bobby
    Zukotynski, Katherine
    Benard, Francois
    Menard, Cynthia
    Kuk, Joda
    Sistani, Golmehr
    Bauman, Glenn
    Veit-Haibach, Patrick
    Metser, Ur
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (06): : 162 - 172
  • [42] Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancer
    Fendler, Wolfgang Peter
    Karpinski, Madeleine J.
    Huesing, Johannes
    Claassen, Kevin
    Moeller, Lennart
    Kajueter, Hiltraud
    Oesterling, Florian
    Gruenwald, Viktor
    Umutlu, Lale
    Lanzafame, Helena
    Telli, Tugce
    Merkel-Jens, Anja
    Huesing, Anika
    Kesch, Claudia
    Herrmann, Ken
    Stang, Andreas
    Hadaschik, Boris A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Perner, SR
    Hofer, MD
    Li, H
    Kuefer, R
    Gschwend, J
    Hautmann, R
    Moeller, P
    Rubin, MA
    LABORATORY INVESTIGATION, 2006, 86 : 155A - 155A
  • [44] Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
    Plichta, Kristin A.
    Graves, Stephen A.
    Buatti, John M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [45] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Michael Sun
    Muhammad Junaid Niaz
    Muhammad Obaid Niaz
    Scott T. Tagawa
    Current Oncology Reports, 2021, 23
  • [46] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Sun, Michael
    Niaz, Muhammad Junaid
    Niaz, Muhammad Obaid
    Tagawa, Scott T.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (05)
  • [47] The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy
    Amit, U.
    Goldstein, J. D.
    Davidson, T.
    Hahiashvili, M.
    Goshen, E.
    Oksman, Y.
    Berger, R.
    Saad, A.
    Sadetsky, I.
    Chikman, B.
    Lawrence, Y. R.
    Ben-Haim, S.
    Symon, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S112 - S113
  • [48] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Perner, SR
    Hofer, MD
    Li, H
    Kuefer, R
    Gschwend, J
    Hautmann, R
    Moeller, P
    Rubin, MA
    MODERN PATHOLOGY, 2006, 19 : 155A - 155A
  • [49] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Hofer, MD
    Perner, S
    Li, HJ
    Kuefer, R
    Hautmann, RE
    Gschwend, JE
    Moeller, P
    Rubin, MA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 155 - 156
  • [50] Advances in Prostate-Specific Membrane Antigen (PSMA)-Targeted Phototheranostics of Prostate Cancer
    Wang, He
    He, Zhangxin
    Liu, Xiao-Ang
    Huang, Yuhua
    Hou, Jianquan
    Zhang, Weijie
    Ding, Dan
    SMALL STRUCTURES, 2022, 3 (08):
12345